NASDAQ: VRDN · Health Care / Biotechnology: Pharmaceutical Preparations

Viridian Therapeutics Inc.

How Viridian Therapeutics Inc. compares with its industry, its sector and the market: price, value, growth, profit and risk.

Market cap

$2.8B

Price

$24.80

P/E

-7.3

EPS (TTM)

$-3.42

1-year return

7.8%

Dividend yield

0.0%

52-week range

$18.22–$29.47

Compared with

• Biotechnology: Pharmaceutical Preparations industry
• Health Care sector

For information only, not investment advice. Data may contain errors. Disclaimer · Sources